HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Silvia R B Uliana Selected Research

Leishmaniasis

7/2023In Vitro Drug Susceptibility of a Leishmania (Leishmania) infantum Isolate from a Visceral Leishmaniasis Pediatric Patient after Multiple Relapses.
11/2021Full nucleotide sequencing of ribosomal DNA internal transcribed spacer of Leishmania species causing cutaneous leishmaniasis in Brazil and its potential for species typing.
12/2019Investigation of the pathways related to intrinsic miltefosine tolerance in Leishmania (Viannia) braziliensis clinical isolates reveals differences in drug uptake.
12/2018Tamoxifen inhibits the biosynthesis of inositolphosphorylceramide in Leishmania.
1/2018Chemotherapy of leishmaniasis: present challenges.
1/2017Susceptibility to Miltefosine in Brazilian Clinical Isolates of Leishmania (Viannia) braziliensis.
12/2015Leishmania is not prone to develop resistance to tamoxifen.
2/2015Generation of luciferase-expressing Leishmania infantum chagasi and assessment of miltefosine efficacy in infected hamsters through bioimaging.
7/2014In vitro and in vivo miltefosine susceptibility of a Leishmania amazonensis isolate from a patient with diffuse cutaneous leishmaniasis.
5/2014Combination therapy with tamoxifen and amphotericin B in experimental cutaneous leishmaniasis.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Silvia R B Uliana Research Topics

Disease

15Leishmaniasis
07/2023 - 05/2005
9Cutaneous Leishmaniasis
11/2021 - 06/2008
8Infections
05/2016 - 05/2005
6Visceral Leishmaniasis (Kala Azar)
07/2023 - 02/2009
3Breast Neoplasms (Breast Cancer)
12/2018 - 09/2007
3Diffuse Cutaneous Leishmaniasis
01/2016 - 06/2008
1Parasitemia
11/2010
1Chagas Disease (American Trypanosomiasis)
11/2010
1Ulcer
06/2008

Drug/Important Bio-Agent (IBA)

12TamoxifenFDA LinkGeneric
12/2018 - 09/2007
6miltefosine (Impavido)IBA
12/2019 - 07/2014
3Meglumine AntimoniateIBA
06/2021 - 01/2010
3LuciferasesIBA
06/2020 - 02/2015
2Ribosomal DNA (rDNA)IBA
07/2023 - 11/2021
2Drug CombinationsIBA
01/2018 - 12/2015
2Selective Estrogen Receptor Modulators (SERM)IBA
05/2014 - 03/2014
1NucleotidesIBA
11/2021
1nanolucIBA
06/2020
1AntigensIBA
01/2016
1Amphotericin B (Amphotericin)FDA LinkGeneric
05/2014
1Estrogen ReceptorsIBA
03/2014
1Proteins (Proteins, Gene)FDA Link
09/2010
1Immune Sera (Antisera)IBA
09/2010
1LimoneneIBA
11/2009
1Estrogen Receptor Modulators (Antiestrogen)IBA
06/2008
1nerolidolIBA
05/2005

Therapy/Procedure

7Drug Therapy (Chemotherapy)
07/2023 - 06/2008
4Therapeutics
01/2018 - 05/2014
1Splenectomy
07/2023
1Intraperitoneal Injections
06/2008